- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 319/04 - 1,3-DioxanesHydrogenated 1,3-dioxanes
Patent holdings for IPC class C07D 319/04
Total number of patents in this class: 34
10-year publication summary
|
2
|
3
|
1
|
0
|
1
|
0
|
2
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| International Business Machines Corporation | 62671 |
2 |
| Merck Patent GmbH | 5729 |
2 |
| Sumitomo Chemical Company, Limited | 8968 |
2 |
| The General Hospital Corporation | 4871 |
2 |
| Takeda Pharmaceutical Company Limited | 2710 |
2 |
| Rhodia Operations | 1491 |
2 |
| BASF SE | 21308 |
1 |
| The Regents of the University of California | 20778 |
1 |
| Centre National de La Recherche Scientifique | 11026 |
1 |
| Dow Global Technologies Inc. | 658 |
1 |
| The Regents of the University of Michigan | 4997 |
1 |
| Northwestern University | 3546 |
1 |
| Bio-Pharm Solutions Co., Ltd. | 55 |
1 |
| BioLab Ltd. | 5 |
1 |
| Central Glass Company, Limited | 1295 |
1 |
| Emcure Pharmaceuticals Limited | 71 |
1 |
| Fukushima Medical University | 42 |
1 |
| IBM United Kingdom Limited | 4079 |
1 |
| JNC Corporation | 1548 |
1 |
| JNC Petrochemical Corporation | 328 |
1 |
| Other owners | 8 |